147 related articles for article (PubMed ID: 38223828)
1. Ginsenoside F2 Restrains Hepatic Steatosis and Inflammation by Altering the Binding Affinity of Liver X Receptor Coregulators.
Kim K; Kim MH; Kang JI; Baek JI; Jeon BM; Kim HM; Kim SC; Jeong WI
J Ginseng Res; 2024 Jan; 48(1):89-97. PubMed ID: 38223828
[TBL] [Abstract][Full Text] [Related]
2. LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
Sim WC; Park S; Lee KY; Je YT; Yin HQ; Choi YJ; Sung SH; Park SJ; Park HJ; Shin KJ; Lee BH
Biochem Pharmacol; 2014 Aug; 90(4):414-24. PubMed ID: 24955981
[TBL] [Abstract][Full Text] [Related]
3. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.
Hwahng SH; Ki SH; Bae EJ; Kim HE; Kim SG
Hepatology; 2009 Jun; 49(6):1913-25. PubMed ID: 19378344
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH
Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738
[TBL] [Abstract][Full Text] [Related]
5. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
Kim JH; Jung DY; Kim HR; Jung MH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside F2 attenuates chronic-binge ethanol-induced liver injury by increasing regulatory T cells and decreasing Th17 cells.
Kim MH; Kim HH; Jeong JM; Shim YR; Lee JH; Kim YE; Ryu T; Yang K; Kim KR; Jeon BM; Kim SC; Jung JK; Choi JK; Lee YS; Byun JS; Jeong WI
J Ginseng Res; 2020 Nov; 44(6):815-822. PubMed ID: 33192125
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
Kay HY; Kim WD; Hwang SJ; Choi HS; Gilroy RK; Wan YJ; Kim SG
Antioxid Redox Signal; 2011 Oct; 15(8):2135-46. PubMed ID: 21504366
[TBL] [Abstract][Full Text] [Related]
8. Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice.
González-Granillo M; Steffensen KR; Granados O; Torres N; Korach-André M; Ortíz V; Aguilar-Salinas C; Jakobsson T; Díaz-Villaseñor A; Loza-Valdes A; Hernandez-Pando R; Gustafsson JÅ; Tovar AR
Diabetologia; 2012 Sep; 55(9):2469-78. PubMed ID: 22739758
[TBL] [Abstract][Full Text] [Related]
9. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
[TBL] [Abstract][Full Text] [Related]
10. 20(S)-protopanaxatriol inhibits liver X receptor α-mediated expression of lipogenic genes in hepatocytes.
Oh GS; Yoon J; Lee GG; Oh WK; Kim SW
J Pharmacol Sci; 2015 Jun; 128(2):71-7. PubMed ID: 26109499
[TBL] [Abstract][Full Text] [Related]
11. Impaired adipose expansion caused by liver X receptor activation is associated with insulin resistance in mice fed a high-fat diet.
Dong Y; Xu Z; Zhang Z; Yin X; Lin X; Li H; Zheng F
J Mol Endocrinol; 2017 Apr; 58(3):141-154. PubMed ID: 28258092
[TBL] [Abstract][Full Text] [Related]
12. Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis.
Lin YN; Chang HY; Wang CCN; Chu FY; Shen HY; Chen CJ; Lim YP
J Agric Food Chem; 2018 Oct; 66(42):10964-10976. PubMed ID: 30351048
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside F2 Suppresses Adipogenesis in 3T3-L1 Cells and Obesity in Mice
Zhou J; Zhang J; Li J; Guan Y; Shen T; Li F; Li X; Yang X; Hu W
J Agric Food Chem; 2021 Aug; 69(32):9299-9312. PubMed ID: 34342980
[TBL] [Abstract][Full Text] [Related]
14. Cinnamamides, Novel Liver X Receptor Antagonists that Inhibit Ligand-Induced Lipogenesis and Fatty Liver.
Sim WC; Kim DG; Lee KJ; Choi YJ; Choi YJ; Shin KJ; Jun DW; Park SJ; Park HJ; Kim J; Oh WK; Lee BH
J Pharmacol Exp Ther; 2015 Dec; 355(3):362-9. PubMed ID: 26384859
[TBL] [Abstract][Full Text] [Related]
15. Sesamin, a Naturally Occurring Lignan, Inhibits Ligand-Induced Lipogenesis through Interaction with Liver X Receptor Alpha (LXR
Tai TS; Tien N; Shen HY; Chu FY; Wang CCN; Lu CH; Yu HI; Kung FP; Chuang HH; Lee YR; Chang HY; Lim YP
Evid Based Complement Alternat Med; 2019; 2019():9401648. PubMed ID: 31976003
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines.
Wang Y; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
J Lipid Res; 2005 Nov; 46(11):2377-87. PubMed ID: 16106051
[TBL] [Abstract][Full Text] [Related]
17. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
[TBL] [Abstract][Full Text] [Related]
18. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
19. The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis.
Burmeister Y; Weyer K; Dörre A; Seilheimer B
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137437
[TBL] [Abstract][Full Text] [Related]
20. A functional cross-talk between liver X receptor-α and constitutive androstane receptor links lipogenesis and xenobiotic responses.
Zhai Y; Wada T; Zhang B; Khadem S; Ren S; Kuruba R; Li S; Xie W
Mol Pharmacol; 2010 Oct; 78(4):666-74. PubMed ID: 20592274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
